Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

46.49 -0.43 (-0.92%)
Official Closing Price Updated: 7:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
75 76 Next >
Tech Stocks Slide On Earnings, US Economy Flexes Muscles, Small-Cap Rally Continues: This Week In The Markets
Tech earnings season disappoints investors with declines in Magnificent Seven stocks. Alphabet, Tesla miss targets, Nasdaq 100 falls 2nd week in a row. 
Via Benzinga
Topics Economy
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
After a turbulent week in the markets, the bulls reclaimed dominance on Wall Street during Friday’s session, with indices and sectors trading in positive territory as investors welcomed the latest... 
Via Benzinga
Topics Economy Stocks
Bristol Myers Squibb Earnings Easily Beat On Cost Cuts; Stock Jumps
The drug giant also raised guidance. 
Via Investor's Business Daily
A Glimpse Into The Expert Outlook On Bristol-Myers Squibb Through 4 Analysts
Via Benzinga
What the Options Market Tells Us About Bristol-Myers Squibb
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Bristol Myers Squibb Jumped Nearly 10% on Friday
The pharmaceutical company is faring far better than most investors were anticipating at this point. 
Via The Motley Fool
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Stocks To Watch Today: 3M, BMY, And Coursera Inc.
Several major companies reported quarterly earnings this week, with 3M, Bristol-Myers Squibb, and Coursera Inc. seeing significant stock price gains. 
Via Talk Markets
Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript
BMY earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
Via Benzinga
BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q2 2024
BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Norfolk Southern Posts Upbeat Earnings, Joins Newell Brands, Charter Communications, 3M And Other Big Stocks Moving Higher On Friday
Via Benzinga
Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs' As Q2 Earnings Beat Expectations, Raises 2024 Profit Forecast
Bristol Myers Squibb reported Q2 revenues of $12.2 billion, surpassing the consensus of $11.55B, driven by its Growth Portfolio and Eliquis. The company's adjusted EPS of $2.07 beat expectations of... 
Via Benzinga
Topics Earnings
US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data
After the severe pounding the tech space received in the past three sessions, it might be rebound time. However, any recovery will largely hinge on whether key inflation data confirms the continued... 
Via Benzinga
Topics Economy
Bristol Myers Squibb Reports Second Quarter Financial Results for 2024
From Bristol Myers Squibb
Via Business Wire
S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone
Via Benzinga
Topics Stocks
Bristol-Myers Squibb, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday
Via Benzinga
DECK, SKX Higher After Earnings; PCE On Tap Friday
It’s tough to get a firm handle on this market. One day it looks like a trading rotation into undervalued equities from big run-ups elsewhere, the next day it’s a major selloff across the board. 
Via Talk Markets
2 High-Yield Dividend Stocks Billionaires Are Buying. Are They Right for You?
Billionaires are buying these stocks, but that doesn't necessarily make them right for your portfolio. 
Via The Motley Fool
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Guggenheim Partners initiated coverage on Alumis, highlighting its lead asset ESK-001, a TYK2 inhibitor for plaque psoriasis and systemic lupus erythematosus. With upcoming Phase 3 trials and no JAK... 
Via Benzinga
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
The aim is to strengthen their drug pipelines and expand their presence in the world's second-largest pharmaceutical market. 
Via Benzinga
3 Defensive Stocks to Shield Your Portfolio in July
Fed Chair Jerome Powell’s cautious economic outlook adds to the allure of defensive stocks offering stable long-term returns 
Via InvestorPlace
Topics Economy
7 Value Stocks to Buy at a 52-Week Low in July
Bottom fishers and contrarians take note: each of these seven value stocks to buy is on sale after recently hitting new 52-week lows. 
Via InvestorPlace
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
The Nasdaq tumbled amid chip woes. 
Via Investor's Business Daily
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. 
Via Benzinga
Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular Carcinoma
From Bristol Myers Squibb
Via Business Wire
Collect $2,000 in Dividends Per Year by Investing $35,000 in These 3 Stocks
These stocks all pay more than four times the S&P 500 average. 
Via The Motley Fool
Topics Stocks
US Bancorp Posts Upbeat Earnings, Joins Aehr Test Systems, Hancock Whitney And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
75 76 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback